AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Aug 17, 2017
34395_dirs_2017-08-17_e75443e8-fe34-4ab0-bc39-24731c458e02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-08-16
Reporting Person: Rootsaert Rodney Gerard (Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-16 | Common Stock | P | 3630 | $2.77 | Acquired | 1007718 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4828 | Direct |
Footnotes
F1: The shares of Common Stock are held directly by Concord International, Inc. Mr. Rootsaert is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30